Kisqali: new oral kinase inhibitor for breast cancer in postmenopausal womenUsed with letrozole, it prolongs progression-free survival compared to letrozole alone Environmental contamination by antineoplastic drugs common in oncology pharmacy and patient care areasNearly half of surface sites tested at 83 Canadian centres had traces of at least one antineoplastic drug Health inequities increase risk of some cancers, Ontario report finds Researchers team up for precision treatment of pancreatic cancer New report on Canadian cancer care outlines what's missing from the patient experience Early MRI may lower costs for prostate cancer treatment More than half of cancer diagnoses now in people 60 to 79: Ontario report Healthcare professionals can help prevent cancer by emphasizing modifiable risk factors Smoking, excess body weight and alcohol intake account for a high proportion of cancer cases Researchers find possible key to progression of prostate cancer A research team at the Université de Sherbrooke has discovered a major biochemical mechanism that could hold the key to the progression of prostate cancer. Study suggests new way to classify cancers, with clinical implications First Previous 27 28 29 30 31 Next Last
